Skip to main content

US FDA Accepts New Drug Application for Treatment of Rare Lung Condition

Submitted by lsekela on September 26, 2017 - 09:27 AM

The inhaled ciprofloxacin formulations are product candidates for the prevention and treatment of high threat and bioterrorism infections. 

Content Source:

Rare Disease Report

Content Author:

Mathew Shanley, Jim Radke

Tags: